our solutions
FLUOROFTA®
FLUOROFTA® is indicated for staining the tear film, to facilitate the removal of a foreign body.
PRODUCT COMPOSITION:
- Fluorescein
- Trehalose
AVAILABLE FORMULATIONS:
- 30 single-dose containers (0.2 ml)
Information from Product’s Package Insert. FLUOROFTA® is a CE 0373 medical device.
LISSAFID
LISSAFID is indicated for the staining of the damaged epithelial cells of the ocular surface, which have lost the ability to produce mucus correctly, and for the staining of the degenerate mucus, in order to facilitate its removal following the diagnosis of ocular surface diseases, such as dry eye syndrome.
PRODUCT COMPOSITION:
- Lissamine green 1.5%
AVAILABLE FORMULATIONS:
- 5 single-dose containers + 5 sterile disposable dispensers
- 30 single-dose containers + 30 sterile disposable dispensers
Information from Product’s Package Insert. LISSAFID is a CE 0546 medical device.
VITREAL S®
VITREAL S® is indicated for the staining of the vitreous body during vitrectomy.
PRODUCT COMPOSITION:
- Triamcinolone Acetonide 4.0%
AVAILABLE FORMULATIONS:
- 2 ml Vial
Information from Product’s Package Insert. VITREAL S® is a CE 0373 medical device.
Discover the science behind Dry Eye Disease
Explore the causes, pathophysiology, and clinical impact of Dry Eye Disease to support informed patient conversations